WeiWangMD

Oncology • San Francisco, CA

Physician

Join to view full profile

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

Office
2100 Webster St
Suite 326
San Francisco, CA 94115
Phone+1 415-885-8600

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 2001 - 2005
University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2001
University of Virginia School of MedicineClass of 1999

Certifications & Licensure

CA State Medical License 2006 - 2025
OR State Medical License 2012 - 2021
PA State Medical License 1994 - 2002
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib Start of enrollment: 2017 Jun 07
Terminated
Phase 3

Publications & Presentations

PubMed

113 citations
Prognostic Value and Function of KLF4 in Prostate Cancer: RNAa and Vector-Mediated Overexpression Identify KLF4 as an Inhibitor of Tumor Cell Growth and Migration
Ji Wang, Robert F. Place, Vera Huang, Xiaoling Wang, Emily J. Noonan
Cancer Research. 2010-12-15
134 citations
Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling
Kristin B. Runkle, Akriti Kharbanda, Ewa Stypulkowski, Xing Jun Cao, Wei Wang
Molecular Cell. 2016-05-05
21 citations
Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors.
Mark Merchant, John Moffat, Gabriele Schaefer, Jocelyn Chan, Xi Wang
Plos One. 2017-01-01

Abstracts/Posters

Identification of Gene Expression Signatures in Leukemia Stem Cells and Minimal Residual Disease Following Treatment of Adverse Risk Acute Myeloid Leukemia
Wei Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

GSK Pancreatic Cancer Drug Heads to Phase 1 Combo with Merck's Keytruda After Positive Mouse TrialNovember 12th, 2018
RIP1 Kinase Identified as Promising Therapeutic Target in Pancreatic CancerNovember 12th, 2018
Drug for Pancreatic Cancer Heralds a New Strategy for Fighting CancerSeptember 11th, 2018